[1]
2021. Huangkui Capsule in Combination with Leflunomide Improves Immunoglobulin A Nephropathy by Inhibiting the TGF-β1/Smad3 Signaling Pathway. Clinics. 76, (Dec. 2021), e2904. DOI:https://doi.org/10.6061/clinics/2021/e2904.